Bone Cement Market Size

The global bone cement market reached an estimated value of USD 1756.90 million in 2024, reflecting a growing reliance on bone fixation materials in orthopaedic surgeries. Bone cement is widely used in joint replacement procedures to anchor implants, particularly in hip, knee, and spinal surgeries. As the global population ages and bone-related disorders become more prevalent, the need for bone cement has expanded. Increased awareness of minimally invasive surgeries and advancements in surgical technology are also contributing to the widespread use of bone cement across hospitals and surgical centres. The rising number of joint reconstructions and trauma cases worldwide continues to sustain the demand for high-quality, reliable bone cements.

Bone Cement Market Growth

The bone cement market is poised for robust growth, driven primarily by the rising volume of orthopaedic procedures, especially joint replacements such as knee and hip arthroplasty. The increasing elderly population is a key factor, as individuals over 60 are more likely to suffer from osteoporosis, arthritis, and fractures that require surgical interventions using bone cement. Additionally, greater participation in sports and physical activities has led to a higher incidence of musculoskeletal injuries, further fuelling demand.

Technological improvements in cement formulations, such as antibiotic-loaded bone cements, have improved safety and reduced post-operative infection risks. Minimally invasive techniques like vertebroplasty and kyphoplasty are also promoting market expansion by offering faster recovery and lower surgical risks. Moreover, the growing availability of orthopaedic care in developing countries and expanding healthcare infrastructure is increasing the accessibility and affordability of surgical procedures, thus supporting market growth across regions.

Download a free sample report, complete with the Table of Contents - https://www.expertmarketresearch.com/reports/bone-cement-market/requestsample

Bone Cement Market Segments

Breakup by Product

  • Calcium Phosphate Cement (CPC): CPC is gaining traction due to its biocompatibility and ability to integrate with natural bone. It is often used in trauma and reconstructive surgeries where bone regeneration is crucial.
  • Glass Polyalkenoate Cement: Though not as widely used as PMMA or CPC, this type is preferred for specific applications that require chemical bonding to bone and metal implants.
  • Polymethyl Methacrylate (PMMA) Cement: PMMA remains the most widely used bone cement type due to its mechanical strength and long-standing clinical success in joint replacements and spinal procedures. It offers immediate fixation and durability, making it suitable for high-load-bearing joints.

Breakup by Application

  • Kyphoplasty: This minimally invasive procedure for treating spinal compression fractures relies heavily on bone cement. The demand is growing among elderly patients with osteoporosis-related spine issues.
  • Arthroplasty: Arthroplasty procedures, including hip and knee replacements, constitute a major application area. Bone cement is critical for anchoring prosthetic joints, especially in older patients.
  • Vertebroplasty: Used in spinal fracture treatments, vertebroplasty involves injecting bone cement into fractured vertebrae to restore strength and stability.
  • Others: Other applications include craniofacial surgeries, trauma cases, and revision surgeries, where bone cement plays a role in structural support and implant fixation.

Breakup by End User

  • Hospitals: Hospitals are the largest end users, equipped with advanced facilities for complex orthopaedic and trauma surgeries. The availability of skilled surgeons and comprehensive care supports high volumes of bone cement use.
  • Clinics: Specialised orthopaedic clinics offer outpatient and short-stay procedures using bone cement in various treatments, particularly for elective surgeries.
  • Ambulatory Surgical Centres: The shift towards day surgeries and minimally invasive techniques is driving the use of bone cement in ambulatory settings due to shorter recovery times and cost benefits.
  • Others: This segment includes academic and research institutions, rehabilitation centres, and veterinary care facilities utilising bone cement in specific use cases.

Breakup by Region

North America
North America dominates the bone cement market, driven by a large ageing population, high awareness of orthopaedic care, and advanced surgical infrastructure. The United States has a high volume of joint replacement and spinal surgeries, supported by favourable reimbursement and technology adoption.

Europe
Europe holds a significant share with strong healthcare systems, increasing surgical procedures, and an ageing population. Countries like Germany, France, and the UK are leading contributors, with emphasis on minimally invasive orthopaedic surgeries.

Asia Pacific
Asia Pacific is witnessing rapid growth due to rising healthcare investments, increasing medical tourism, and growing awareness about bone-related diseases. Countries such as China, India, and Japan are expanding their orthopaedic services and facilities, boosting the use of bone cement.

Latin America
The Latin American market is growing steadily with improvements in healthcare access and an increase in trauma and orthopaedic surgeries. Brazil and Mexico are key regional markets with expanding surgical infrastructure.

Middle East and Africa
In the Middle East and Africa, growth is supported by healthcare modernisation and rising demand for orthopaedic services. While still emerging, countries like the UAE and South Africa are adopting advanced medical technologies, including bone cement in surgical practices.

Bone Cement Market Forecast

The global bone cement market is projected to grow at a compound annual growth rate (CAGR) of 6.50% between 2025 and 2034. By 2034, the market is expected to reach approximately USD 3297.94 million. This steady growth reflects the rising incidence of orthopaedic disorders, increasing surgical volumes, and advancements in cement technology. With healthcare accessibility improving worldwide and an ageing global population, the demand for reliable and durable bone cement products will continue to rise. Additionally, manufacturers focusing on biocompatible and antibiotic-loaded formulations will further drive the adoption of bone cement in diverse surgical applications.

Market Key Players

  • DJO, LLC
  • Stryker Corporation
  • Smith & Nephew Plc
  • Arthrex, Inc.
  • Tecres S.p.A.
  • Heraeus Holding GmbH
  • Teknimed
  • Zimmer Biomet
  • DePuy Synthes

These companies lead the global bone cement market through innovation, wide product portfolios, and strong distribution networks. They are investing in R&D to enhance bone cement formulations for improved patient outcomes. Strategic collaborations, mergers, and geographic expansions are key strategies to maintain competitive advantage and cater to the growing demand across healthcare facilities worldwide.